Family History and Cardiovascular Risk in Familial Hypercholesterolemia
- 25 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (11) , 1473-1478
- https://doi.org/10.1161/01.cir.0000058166.99182.54
Abstract
Background— Elevated LDL cholesterol (LDL-C) levels in childhood predict cardiovascular disease (CVD) later in life. Familial hypercholesterolemia (FH) represents the paradigm of this relation. Methods and Results— The objectives of this study were to (1) establish the LDL-C level that provides the most accurate diagnosis of FH in children from families with known FH and (2) assess whether lipoprotein variation in these children is associated with premature CVD in relatives. Foremost, however, it was our objective to identify children with FH who are at high risk and in need of early intervention. A total of 1034 consecutive children from FH kindreds were investigated. First, LDL-C levels >3.50 mmol/L had a 0.98 post-test probability (95% CI, 0.96 to 0.99) of predicting the presence of an LDL receptor mutation. Second, children with FH in the highest LDL-C tertile (>6.23 mmol/L) had a 1.7-times higher incidence (95% CI, 1.24 to 2.36) of having a parent with FH suffering from premature CVD (P=0.001). In addition, such a parent was found 1.8 times more often (95% CI, 1.20 to 2.59) among children with FH who had HDL-C 300 mg/L had a 1.45-times higher incidence (95% CI, 0.99 to 2.13) of having a parent with FH suffering from premature CVD (P=0.05). Conclusions— In FH families, LDL-C levels allow accurate diagnosis of FH in childhood. Moreover, increased LDL-C and lipoprotein(a) and decreased HDL-C levels in children identify FH kindreds with the highest CVD risk.Keywords
This publication has 20 references indexed in Scilit:
- The molecular basis of familial hypercholesterolemia in The NetherlandsHuman Genetics, 2001
- Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic diseaseBMJ, 2001
- Family History of Coronary Heart Disease, a Strong Risk Factor for Myocardial Infarction Interacting with Other Cardiovascular Risk Factors: Results from the Stockholm Heart Epidemiology Program (SHEEP)Epidemiology, 2001
- Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.Journal of Clinical Investigation, 1997
- Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemiaThe Journal of Pediatrics, 1996
- Follow up study on children with dyslipidaemia detected by mass screening at 18 months of age: effect of 12 months dietary treatmentEuropean Journal of Pediatrics, 1993
- Importance of diet in the treatment of familial hypercholesterolemiaThe American Journal of Cardiology, 1993
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Enhanced Cholesteryl Ester Transfer Protein Activities and Abnormalities of High Density Lipoproteins in Familial HypercholesterolemiaHormone and Metabolic Research, 1992
- Familial Hypercholesterolemia (One Form of Familial Type II Hyperlipoproteinemia) A STUDY OF ITS BIOCHEMICAL, GENETIC, AND CLINICAL PRESENTATION IN CHILDHOODJournal of Clinical Investigation, 1974